Creating new catalysts for important chemical transformations
Official title: Developing Selective P-catalysts for Dehydrative Transformations
Funded at Massachusetts Institute of Technology · NIH-11014987 · Data updated 2026-11-12
This study is all about creating special tools that help make important chemicals used in medicines more easily and efficiently, so we can improve how we develop new drugs.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Massachusetts Institute of Technology NIH-funded |
| Lab location | 1 site (Cambridge, United States) |
| Project start | February 1, 2024 |
| Project end | January 31, 2026 |
| Funding year | 2025 |
| Award (this year) | $76,756 |
| NIH project number | 5F32GM153091-02 |
| Project ID | NIH-11014987 on NIH RePORTER |
Who could benefit from this research
✓Could help
Patients who may benefit from this research are those with conditions that could be treated by new drugs developed from the synthesized compounds.
✕Less likely to help
Patients with conditions unrelated to the pharmaceutical applications of the synthesized compounds may not receive any benefit from this research.
What this research studies
This research focuses on developing specialized catalysts that can facilitate the transformation of certain chemical compounds, specifically through processes called amidation and amide functionalization. By understanding the steric and electronic properties of these catalysts, the research aims to improve the synthesis of biologically active compounds, which are crucial for pharmaceuticals. The project will involve both experimental and computational methods to design and test these catalysts, ultimately aiming for efficient one-pot synthesis of valuable chemical products.
Why it matters
Potential benefit: If successful, this research could lead to more efficient methods for producing important pharmaceutical compounds.
How similar studies have gone: Other research in catalyst development has shown significant success, indicating that this approach has the potential for meaningful advancements.
Where this research is happening
-
Massachusetts Institute of Technology
Cambridge, United States Active
Researchers
- Principal investigator: Ali, Siraj Zaki — Massachusetts Institute of Technology
- Study coordinator: Ali, Siraj Zaki
Related research
Other NIH-funded projects on the same topics.
-
PhysioNet: A trusted, open data repository for clinical and physiological data
A publicly accessible platform provides curated clinical and physiological data and tools to help researchers develop and test AI models for better healthcare.
-
Dormancy in Triple-Negative Breast Cancer: How Liver and Skin Metastases Go Quiet or Reactivate
Researchers will study how dormant cancer cells in liver and skin metastases of triple-negative breast cancer become quiescent or wake up, using organ-on-chip models and single-cell analysis to map chromatin states.
-
Single-cell, label-free mapping of senescence in tissues with Raman imaging and spatial genomics
A project to map how senescent cells differ across tissues using a noninvasive Raman imaging method combined with spatial genomics.
-
Structures and dynamics of virus ion channels
This project studies the tiny channels in certain influenza and coronavirus viruses to understand how they let ions pass through and contribute to disease.
-
Prospect: Stem Cell Models for Early-Onset Colorectal Cancer Prevention
Researchers at MIT are using stem cell models to understand why colorectal cancer is rising in people under 50 and how to prevent it.
-
MATCHMAKERS: AI tools to predict TCR binding and design
Researchers are building AI tools to predict how T cell receptors recognize tumor antigens, with aims to help improve targeted immunotherapies.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.